Autres langues Sichuan Kelun Pharmaceutical Co., Ltd.

Actions

002422

CNE100000PW7

Cours en clôture Shenzhen S.E. Autres places de cotation 00:00:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
30,33 ^CNY	-1,33 %		-3,81 %	+4,41 %

25/04	Sichuan Kelun Pharmaceutical Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
10/04	Sichuan Kelun Pharmaceutical Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sichuan Kelun Pharmaceutical Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 29 May 2024	23/05
Sichuan Kelun Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023	25/04
Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	10/04
US FDA to Accelerate Review of Kelun Pharma Unit's Lung Cancer Drug	12/03
Kelun-Biotech Controlling Shareholder Ups Stake; Shares Rise 4%	23/01
Kelun Pharmaceutical's Olaparib Tablets Get Nod from Chinese Drug Regulator	22/01
Kelun Pharma Gets Registration Approval in China for Immune Thrombocytopenia Drug	17/01
Kelun Pharma Sees Up to 50% Jump in 2023 Profit	16/01
Kelun Pharma's Unit Gets US FDA's Orphan Drug Designation to A400	28/11
Kelun Pharmaceutical's Unit Gains Registration Certificate for Ceftazidime Avibactam Sodium/Sodium Chloride Injection	01/11
Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Kelun Pharma Ends Cancer Drug Contract, Revises Partnership With Merck	24/10/23
Global markets live: Foxconn, Roche, Eli Lilly, Chevron, Apple...	23/10/23
The good, the bad and the ugly	23/10/23
Merck discontinues some cancer drug development with China's Sichuan Kelun	23/10/23
Kelun Pharma Unit Obtains Registration Approval in China for Bacterial Infection Drug	18/10/23
Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Sichuan Kelun Pharma to Start License Application Process For New Cancer Drug	15/08/23
Kelun Pharma's Unit Gets Gadobutrol injection Certified	13/07/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Sichuan Kelun Pharmaceutical Co., Ltd.

Actions

002422

CNE100000PW7

Autres langues

Filtres